Post-partum Perineal Pain - Chirocaine®

Contribution of the Local Infiltration of Chirocaine® in the Management of the Post-partum Perineal Pain After Episiotomy or First-degree Tear

The aim of this placebo-controlled clinical trial is to assess the effectiveness of the local infiltration of the analgesic Chirocaïne® on perineal pain after episiotomy or first-degree tear. The pain intensity is measured in immediate postpartum period by using a numerical rating scale (NRS) at the following times: H2, H4, H8, H12, H24, H36, H48 during rest, defecation and during activities. The safety of Chirocaïne® and the patient satisfaction are also evaluated at each time.

Inclusion Criteria:

• Inclusion Criteria:
• Patients aged 18-45 years
• Single pregnancy.
• Vaginal normal birth in cephalic presentation or assisted vaginal delivery by vacuum extractor.
• Patients having a mediolateral episiotomy or a first-degree perineal tear, epidural analgesia.
• Patients affiliated to a national insurance scheme
• Patients who have given their written consent

Exclusion Criteria:

• Patient not speaking, reading, writing French.
• Multiple pregnancy.
• Breech delivery or instrumental delivery by forceps or spatula.
• Intact perineum.
• No epidural analgesia.
• Patient who represent contraindication to local anesthetics, severe arterial hypotension.
• Previous tear requiring sutures.